Recent advances in the management of proliferative diabetic... : Current Opinion in
Ophthalmology Recent advances in the management of proliferative diabetic retinopathy …

Objective To systematically review and perform a meta-analysis on the available evidence
for anti-vascular endothelial growth factor (anti-VEGF) monotherapy versus panretinal …

Purpose The COVID-19 pandemic has had a profound effect on the delivery of healthcare in
the United States and globally. The aim of this study was to evaluate the impact of COVID-19 …

To compare changes in retinal layers and microvasculature in diabetic retinopathy (DR)
patients after bevacizumab therapy and panretinal photocoagulation (PRP). This …

Purpose To highlight the financial incentive to the physician of choosing an intravitreal anti-
vascular endothelial growth factor (VEGF)-based strategy for treating non-proliferative and …

Importance While combined treatment of anti–vascular endothelial growth factor (VEGF)
injections plus panretinal photocoagulation (PRP) is a common approach for treating …

Objective The purpose of this study is to investigate the potential of using the tortuosity of
branch retinal artery as a more promising indicator for early detection and accurate …

Background: Ranibizumab addition may benefit to improve the efficacy in patients with
diabetic retinopathy than only photocoagulation, and this meta-analysis aims to explore the …

Purpose This study examined how treatment patterns for proliferative diabetic retinopathy
(PDR) have changed over time using clinical registry data from the AAO IRIS® Registry …

Asteroid hyalosis (AH) is a benign clinical entity characterized by the presence of multiple
refractile spherical calcium and phospholipids within the vitreous body. First described by …